Genetic Technologies: Acquires EasyDNA for $5.4M

Genetic Technologies Acquires EasyDNA for $5.4M

  • Genetic Technologies (GTG) acquires EasyDNA for around $5.4 million in cash and scrip
  • Under the contract, GTG obtains all of Belhealth’s websites, lab testing and distribution agreements associated with its EasyDNA business
  • EasyDNA sells paternity, oncology and health genomics-based laboratory tests, with agreements across 12 labs in North America, Europe and Asia
  • GTG says it will onboard the existing EasyDNA team, retaining the skills of all employees based in Malta and Australia
  • The company says the acquisition will provide it with the foundation to grow its portfolio of serious disease tests across well-established websites in 40 countries
  • The company closed flat at 0.8 cents per share
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FundBank Strengthens Position with Acquisition of TRRUE Blockchain Firm

The acquisition enhances FundBank's capabilities in blockchain technology.Highlights: FundBank has acquired the Irish blockchain firm, TRRUE.The acquisition aims...

Visa Strengthens Ties as Anchor Investor in PayPay IPO

Visa commits to supporting PayPay's growth through IPO investment.Highlights: Visa invests as anchor in PayPay's IPO.This move highlights...

Santander and Mastercard Complete Europe’s First Live Agentic AI Transaction

This groundbreaking transaction marks a milestone in AI-driven financial technology.Highlights: Santander and Mastercard execute Europe’s first agentic AI...

Apple Strengthens Reach with Apple Pay Launch in India

Apple Pay expands its footprint, aiming to capture the Indian digital payments market.Highlights: Apple Pay officially launches in...